Education
About Us
Working with TipRanks
Follow Us
HitIQ Limited (AU:HIQ)
ASX:HIQ
HIQ Stock Chart & Stats
AU$0.02
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.02
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.05
Previous CloseN/A
Volume134.14K
Average Volume (3M)233.78K
Market Cap
AU$10.57M
Enterprise ValueAU$7.51M
Total Cash (Recent Filing)AU$990.96K
Total Debt (Recent Filing)AU$5.66M
Price to Earnings (P/E)―
Beta1.29
Next Earnings
Feb 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding528,291,560
10 Day Avg. Volume147,164
30 Day Avg. Volume233,782
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)-1.60
Price to Sales (P/S)3.20
P/FCF Ratio-1.38
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HitIQ Limited News
HIQ FAQ
What was HitIQ Limited’s price range in the past 12 months?
HitIQ Limited lowest share price was AU$0.01 and its highest was AU$0.05 in the past 12 months.
What is HitIQ Limited’s market cap?
HitIQ Limited’s market cap is AU$10.57M.
When is HitIQ Limited’s upcoming earnings report date?
HitIQ Limited’s upcoming earnings report date is Feb 26, 2026 which is in 67 days.
How were HitIQ Limited’s earnings last quarter?
HitIQ Limited released its earnings results on Aug 29, 2025. The company reported -AU$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.009.
Is HitIQ Limited overvalued?
According to Wall Street analysts HitIQ Limited’s price is currently Overvalued.
Does HitIQ Limited pay dividends?
HitIQ Limited does not currently pay dividends.
What is HitIQ Limited’s EPS estimate?
HitIQ Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HitIQ Limited have?
HitIQ Limited has 528,291,560 shares outstanding.
What happened to HitIQ Limited’s price movement after its last earnings report?
HitIQ Limited reported an EPS of -AU$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of HitIQ Limited?
Currently, no hedge funds are holding shares in AU:HIQ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
HitIQ Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
AU:HIQ Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$8.4K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-19.23%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-12.11%
Trailing 12-Months
Company Description
HitIQ Limited
HitIQ Limited engages in development and commercialization of concussion management technology in Australia. Its Nexus software provides comprehensive head impact data and analysis to make informed decisions to improve the quality of care for athletes. It also offers CoVR, a virtual reality based cognitive and oculomotor assessment platform, which identifies impairments across domains, such as hand-eye coordination, memory, and decision making; and CSX that provides an easy to use, sideline concussion assessment tool, which produces a digital record that can be shared with medical professionals, family, and organizations to take coordinated athlete care. The company was incorporated in 2015 and is based in Melbourne, Australia.
Technical Analysis
Resonance Health Ltd
―
Global Health Limited
―
Singular Health Group Ltd
―
Emyria Ltd
―
InteliCare Holdings Limited
―
Options Prices
Currently, No data available
---